Garth Cumberlidge

President, Director & Chief Executive Officer at SemaThera Inc - Westmount, QC, CA

Garth Cumberlidge's Contact Details
HQ
N/A
Location
Greater Boston
Company
SemaThera Inc
Garth Cumberlidge's Company Details
SemaThera Inc logo, SemaThera Inc contact details

SemaThera Inc

Westmount, QC, CA • 5 - 9 Employees
BioTech/Drugs

SemaThera is a spin-off company from AmorChem Fund 1, which focuses on a novel target, semaphorin 3A (SEMA3A). The Company is currently developing bispecific SEMA3A / VEGF inhibitors (traps) to prevent vascular leakage and damper the inflammation in diabetic macular edema (DME). The technology targets the 30% DME patients who are poor responders to current anti-VEGF therapies.

diabetic macular edema ocular diseases semaphorin 3A
Details about SemaThera Inc
Frequently Asked Questions about Garth Cumberlidge
Garth Cumberlidge currently works for SemaThera Inc.
Garth Cumberlidge's role at SemaThera Inc is President, Director & Chief Executive Officer.
Garth Cumberlidge's email address is ***@semathera.com. To view Garth Cumberlidge's full email address, please signup to ConnectPlex.
Garth Cumberlidge works in the BioTech/Drugs industry.
Garth Cumberlidge's colleagues at SemaThera Inc are Francois Binet, Véronique Bougie, Normand Beaulieu, Michelle Barbagallo and others.
Garth Cumberlidge's phone number is N/A
See more information about Garth Cumberlidge